Wei Zhang, Ph.D.

University of California, San Francisco, San Francisco, CA 
Mechanotransduction, Hearing
"Wei Zhang"
Mean distance: 13.81 (cluster 11)
Cross-listing: CSD Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Miao X, Yu F, Liu K, et al. (2022) High special surface area and "warm light" responsive ZnO: Synthesis mechanism, application and optimization. Bioactive Materials. 7: 181-191
Zhong H, Yu M, Lin P, et al. (2021) Molecular landscape of DYSF mutations in dysferlinopathy: from a Chinese multicenter analysis to a worldwide perspective. Human Mutation
Allamneni C, Vora RS, Bamidele AO, et al. (2021) Hepatology Highlights. Hepatology (Baltimore, Md.). 74: 1727-1729
Zhang W, Tang Y, Liu H, et al. (2021) Risk prediction models for intensive care unit-acquired weakness in intensive care unit patients: A systematic review. Plos One. 16: e0257768
Qiu K, Pang W, Qiu J, et al. (2021) Evaluating the prognostic contributions of TNM classifications and building novel staging schemes for middle ear squamous cell carcinoma. Cancer Medicine
Zhang W, Huang Z, Zhang J, et al. (2021) Long-term and short-term outcomes after laparoscopic versus open surgery for advanced gastric cancer: An updated meta-analysis. Journal of Minimal Access Surgery. 17: 423-434
Wang L, Fu Z, Deng W, et al. (2021) Maternal fish and shellfish consumption and preterm birth: A retrospective study in urban China. The British Journal of Nutrition. 1-31
Qu X, Zhang J, Wang Q, et al. (2021) Edentulism and select chronic diseases among adults aged ≥45 years in China, 2011-2018: A longitudinal study. Community Dentistry and Oral Epidemiology
Xie L, Wang G, Wu Y, et al. (2021) Programmed surface on poly(aryl-ether-ether-ketone) initiating immune mediation and fulfilling bone regeneration sequentially. Innovation (New York, N.Y.). 2: 100148
Zhang W, Chen Z, Xue C, et al. (2021) The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma. Frontiers in Medicine. 8: 740029
See more...